These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 38772678)
21. A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid. Alborizi A; Hosseini-nasab A; Zeyaeian M; Sanaei A; Kashef S Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):117-9. PubMed ID: 19671942 [TBL] [Abstract][Full Text] [Related]
22. A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress Continues. Frisch ES; Pretzsch R; Weber MS Neurotherapeutics; 2021 Jul; 18(3):1602-1622. PubMed ID: 33880738 [TBL] [Abstract][Full Text] [Related]
23. Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1. Hassan R; Williams-Gould J; Watson T; Pai-Scherf L; Pastan I Clin Cancer Res; 2004 Jan; 10(1 Pt 1):16-8. PubMed ID: 14734446 [TBL] [Abstract][Full Text] [Related]
24. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Levi ME; Quan D; Ho JT; Kleinschmidt-Demasters BK; Tyler KL; Grazia TJ Clin Transplant; 2010; 24(2):223-8. PubMed ID: 19659514 [TBL] [Abstract][Full Text] [Related]
25. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature. Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241 [TBL] [Abstract][Full Text] [Related]
26. Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD. Mears V; Jakubecz C; Seeco C; Woodson S; Serra A; Abboud H J Neuroimmunol; 2023 Apr; 377():578066. PubMed ID: 36917920 [TBL] [Abstract][Full Text] [Related]
27. [Agammaglobulinemia with the absence of circulating B-lymphocytes. 9 cases]. Bejaoui M; Barbouche MR; Mellouli F; Tirellil N; Dellagi K Presse Med; 1998 Mar; 27(12):562-6. PubMed ID: 9767948 [TBL] [Abstract][Full Text] [Related]
28. Treatment of multiple sclerosis with anti-CD20 antibodies. Barun B; Bar-Or A Clin Immunol; 2012 Jan; 142(1):31-7. PubMed ID: 21555250 [TBL] [Abstract][Full Text] [Related]
29. Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice. Kolomansky A; Kaye I; Ben-Califa N; Gorodov A; Awida Z; Sadovnic O; Ibrahim M; Liron T; Hiram-Bab S; Oster HS; Sarid N; Perry C; Gabet Y; Mittelman M; Neumann D Front Immunol; 2020; 11():561294. PubMed ID: 33193330 [TBL] [Abstract][Full Text] [Related]
30. Detection of enterovirus RNA in cerebrospinal fluid: comparison of two molecular assays. de Crom SC; Obihara CC; van Loon AM; Argilagos-Alvarez AA; Peeters MF; van Furth AM; Rossen JW J Virol Methods; 2012 Jan; 179(1):104-7. PubMed ID: 22024398 [TBL] [Abstract][Full Text] [Related]
32. Enteroviral Meningoencephalitis as a Complication of Rituximab Therapy for Rheumatoid Arthritis. Cook SG; Ford AW; Lindholm DA; Scott J Cureus; 2021 Sep; 13(9):e18189. PubMed ID: 34707960 [TBL] [Abstract][Full Text] [Related]
33. Proteomic Analysis of Cerebrospinal Fluid in Children with Acute Enterovirus-Associated Meningoencephalitis Identifies Dysregulated Host Processes and Potential Biomarkers. Sun Z; Li W; Xu J; Ren K; Gao F; Jiang Z; Ji F; Pan D J Proteome Res; 2020 Aug; 19(8):3487-3498. PubMed ID: 32678604 [TBL] [Abstract][Full Text] [Related]
34. γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Braza MS; Klein B; Fiol G; Rossi JF Haematologica; 2011 Mar; 96(3):400-7. PubMed ID: 21109686 [TBL] [Abstract][Full Text] [Related]
35. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623 [TBL] [Abstract][Full Text] [Related]